Insights

News, Technical Notes, Videos and more.

VIDEO – A new approach to designing synthetic affinity ligands for enhanced viral vector analytics and purification

Our Head of Cell and Gene Therapy Applications, Abdullah Sufan presented ‘A new approach to designing synthetic affinity ligands for enhanced viral vector analytics and purification’ at Bioprocessing Summit 2024.…

Learn more

Research

Novel synthetic affinity reagents for lentivirus analytics and capture chromatography – Presented at The Bioprocessing Summit 2024

First presented at The Bioprocessing Summit 2024, this poster introduces a new suite of synthetic affinity reagents targeting VSV-G, a lentivirus envelope protein for viral vector analytics and purification. Smart…

Learn more

NEWS

MIP Discovery rebrands as Tozaro as it completes transition…

Learn more

RESEARCH

Developing new tools for rapid quantification of viral vectors…

Learn more

NEWS

Tozaro closes £7M Series A financing to drive commercialization…

Learn more

NEWS

MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification

Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral vectors in cell and gene therapy Rebrand follows Series…

Learn more

NEWS

Tozaro closes £7M Series A financing to drive commercialization in cell and gene therapy space

Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia…

Learn more

NEWS

Tozaro (formally MIP Discovery) secures significant funding to support…

Learn more

Insights

Fill in the form below to complete your download